Similar to the severe SMA mouse model, Smn2B/− mice display a significant reduction in Klf15 mRNA expression in pre-symptomatic muscle (TA) followed by a significant upregulation during disease progression compared to age-matched WT animals (Fig. 5a). Here, KLF15 is linked to proximal spinal muscular atrophy.